Truveta
Truveta raises $320M Growth at $1B valuation
Quick Facts
Truveta: Growth Funding Round
Truveta has successfully raised $320M in Growth funding, reaching a valuation of $1B.
Company Overview
Medical data research platform aggregating health system data for clinical insights
Funding Details
The Growth round was led by Regeneron Pharmaceuticals, with participation from Illumina.
Company Information
- Headquarters: Seattle, WA
- Founded: 2021
- Employees: 400+
- Category: HealthTech
Investment
Truveta plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Regeneron Pharmaceuticals: Verified investor in Growth
- Illumina: Verified investor in Growth
Key Investors
About the Author
Related Company Reports
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
DermaSensor raises $16M Series B at $85M valuation
DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.
